Jr. Scientist (Lateral Flow Assay)

Summary of the role:

This is an exciting R&D opportunity in an innovation-focused company to develop new in vitro diagnostic assays on our Lateral Flow Assay (LFA) platform.

Roles & Responsibilities:

• 
  Independently execute complex test programs and individual experiments in alignment with general guidelines.
• Participate in the systematic assessment of input materials, formulations, and setups for lateral flow immunoassays.
• Contribute to the methodical development of system dependencies for dry chemical test systems.
• Produce and evaluate laboratory samples.
• Collect data to support the creation of manufacturing and testing protocols.
• Mathematically and statistically analyze and interpret test results using IT tools.
• Document and evaluate experimental test procedures and results in detailed protocols.
• Generate specification documents, including manufacturing instructions, forms, and Standard Operating Procedures (SOPs).
• Plan individual experiments for test and system development based on general specifications or in consultation with supervisors.

Qualifications:

• 
  Engineer (Master's or Bachelor's degree) or highly experienced technician in disciplines such as biochemistry or biology.
• Significant professional background in Research and Development (R&D) within In Vitro Diagnostics (IVD) development.
• Additional experience in lateral flow immunoassays is advantageous.
• Proficiency in handling human-origin sample materials like whole blood, plasma, and serum.
• Strong command of MS Office applications (Excel, PowerPoint).
• Excellent proficiency in English language.

About the company:

Achira Labs (http://www.achiralabs.com) is a pioneering Bangalore-based company that has developed proprietary lab-on-chip (microfluidics) platforms to perform rapid and reliable blood tests in near-patient settings. The company’s culture encourages innovation and team participation at all levels and boasts a strong track record for creating globally relevant innovative technology solutions. Achira has built India’s first microfluidics-based platform for point-of-care immunodiagnostics through in-house efforts combining diverse areas including portable electronics, microfluidics, assay development and materials chemistry. Achira’s work is backed by 24 issued international patents, multiple peer-reviewed publications, many industry collaborations and several research grants from national and international funding agencies including BIRAC, Grand Challenges Canada, ICMR, DST etc. Achira has received the National Technology Award in India for new technologies (Biotechnology) from the President of India as well as MIT Technology Review’s prestigious TR35 awards in recognition of our work. Achira is well capitalized and is supported by marquee investors including Catamaran and Cipla.